Christina Manyama

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse et al. · The Lancet Infectious Diseases · 2016 · 379 citations · Full text

Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries

Laura Olbrich, Valsan Philip Verghese, Zoe Franckling-Smith et al. · The Lancet Infectious Diseases · 2023 · 42 citations · Full text

Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: A prospective, multi-centre evaluation

Klaus Reither, Christina Manyama, Petra Clowes et al. · Journal of Infection · 2014 · 29 citations

Pulmonary Tuberculosis, Medicine, Clinical Epidemiology +11

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

Norbert Heinrich, Veronique de Jager, Julia Dreisbach et al. · The Lancet Microbe · 2025 · 16 citations · Full text

Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa

Chad M. Centner, Rahmawati Munir, Elisa Tagliani et al. · Open Forum Infectious Diseases · 2024 · 11 citations · Full text